T1	CHEM 27 37	colutorios
#1	AnnotatorNotes T1	C0026647; Mouthwash; Biomedical or Dental Material
T2	PROC 46 57	tratamiento
#2	AnnotatorNotes T2	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T3	DISO 64 78	halitosis oral
#3	AnnotatorNotes T3	C0018520; Halitosis; Sign or Symptom
T4	DISO 93 112	halitosis intraoral
#4	AnnotatorNotes T4	C0018520; Halitosis; Sign or Symptom
T5	ANAT 176 188	cavidad oral
#5	AnnotatorNotes T5	C0226896; Oral cavity; Body Space or Junction | C0230028; Oral region; Body Location or Region | C1267547; Entire mouth region; Body Location or Region
T6	PROC 747 778	distribuidos de forma aleatoria
#6	AnnotatorNotes T6	C0034656; Randomization; Research Activity
T7	DISO 208 219	mal aliento
#7	AnnotatorNotes T7	C0018520; Halitosis; Sign or Symptom
T8	CHEM 255 258	CVS
T9	PROC 338 349	tratamiento
#8	AnnotatorNotes T9	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T10	DISO 356 365	halitosis
#9	AnnotatorNotes T10	C0018520; Halitosis; Sign or Symptom
T11	PROC 394 404	enmascarar
T12	CHEM 460 463	CVS
T13	PROC 569 581	tratamientos
#10	AnnotatorNotes T13	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T14	PROC 617 655	estudio piloto doble ciego, controlado
#11	AnnotatorNotes T14	C0031928; Pilot Projects; Research Activity + C0013072; Double-Blind Method; Research Activity + C0681867; Controlled Study; Research Activity
T15	PROC 698 712	diagnosticados
#12	AnnotatorNotes T15	C0011900; Diagnosis; Diagnostic Procedure
T16	DISO 716 735	halitosis intraoral
#13	AnnotatorNotes T16	C0018520; Halitosis; Sign or Symptom
T17	PROC 834 845	tratamiento
#14	AnnotatorNotes T17	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T18	CHEM 886 901	cloruro de zinc
#15	AnnotatorNotes T18	C0078774; zinc chloride; Pharmacologic Substance · Inorganic Chemical
T19	CHEM 903 910	alcohol
#16	AnnotatorNotes T19	C0001962; ethanol; Organic Chemical · Pharmacologic Substance
T20	CHEM 942 957	cloruro de zinc
#17	AnnotatorNotes T20	C0078774; zinc chloride; Pharmacologic Substance · Inorganic Chemical
T21	CHEM 966 981	lactato de zinc
#18	AnnotatorNotes T21	C2240534; zinc lactate; Organic Chemical · Pharmacologic Substance
T22	CHEM 1051 1069	medicación placebo
#19	AnnotatorNotes T22	C1696465; placebo; Biomedical or Dental Material
T23	CHEM 1550 1553	VSC
T24	PROC 1074 1085	tratamiento
#20	AnnotatorNotes T24	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T25	PROC 1164 1176	nivel de CVS
T26	CHEM 406 420	antibacteriano
#21	AnnotatorNotes T26	C0279516; Anti-Bacterial Agents; Antibiotic
T27	CHEM 1314 1317	CVS
T28	PROC 1388 1400	tratamientos
#22	AnnotatorNotes T28	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T29	PROC 1449 1458	protocolo
#23	AnnotatorNotes T29	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T30	PROC 1506 1518	tratamientos
#24	AnnotatorNotes T30	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T31	DISO 1574 1588	halitosis oral
#25	AnnotatorNotes T31	C0018520; Halitosis; Sign or Symptom
T32	ANAT 74 78	oral
#26	AnnotatorNotes T32	C0226896; Oral cavity; Body Space or Junction | C0230028; Oral region; Body Location or Region | C1267547; Entire mouth region; Body Space or Junction
T33	CHEM 859 868	triclosan
#27	AnnotatorNotes T33	C0040958; Triclosan; Organic Chemical · Pharmacologic Substance
T34	ANAT 212 219	aliento
#28	AnnotatorNotes T34	C0225386; Breath; Body Substance
T35	CHEM 222 253	compuestos volátiles sulfurados
T36	CHEM 870 884	fluorurosódico
#29	AnnotatorNotes T36	C0037508; Sodium Fluoride; Inorganic Chemical
T37	PROC 531 551	comparar la eficacia
#30	AnnotatorNotes T37	C1707887; Efficacy Study; Research Activity
T38	CHEM 926 940	fluorurosódico
#31	AnnotatorNotes T38	C0037508; Sodium Fluoride; Inorganic Chemical
T39	CHEM 989 1001	chorhexidina
#32	AnnotatorNotes T39	C0008196; chlorhexidine; Organic Chemical · Pharmacologic Substance
T40	CHEM 1009 1035	clorururo de cetilpiridino
#33	AnnotatorNotes T40	C0007906; cetylpyridinium; Organic Chemical · Pharmacologic Substance
T41	CHEM 1173 1176	CVS
T42	ANAT 1584 1588	oral
#34	AnnotatorNotes T42	C0226896; Oral cavity; Body Space or Junction | C0230028; Oral region; Body Location or Region | C1267547; Entire mouth region; Body Space or Junction
T43	CHEM 915 924	triclosan
#35	AnnotatorNotes T43	C0040958; Triclosan; Organic Chemical · Pharmacologic Substance
T46	Date 290 294	1977
T48	LIVB 678 697	sujetos voluntarios
#36	AnnotatorNotes T48	C0020155; Human Volunteers; Population Group
T49	LIVB 797 804	sujetos
#37	AnnotatorNotes T49	C0681850; Study Subject; Group
T50	Dose 1097 1101	10ml
T51	Duration 1122 1131	3 semanas
T56	Date 1554 1567	a corto plazo
T44	Dose 982 987	0,14%
T45	Dose 1002 1007	0,05%
T47	Dose 1036 1041	0,05%
T52	Frequency 1102 1113	2 veces día
R1	Used_for Arg1:T1 Arg2:T2	
R2	Location_of Arg1:T32 Arg2:T3	
R3	Location_of Arg1:T5 Arg2:T4	
R4	Causes Arg1:T35 Arg2:T7	
R5	Causes Arg1:T8 Arg2:T7	
T53	Neg_cue 467 469	no
T54	Quantifier_or_Qualifier 470 479	volátiles
A1	Assertion T54 Negated
#38	AnnotatorNotes T54	C1963547; Volatile (qualifier value) Qualitative Concept
R6	Negation Arg1:T53 Arg2:T54	
R7	Has_Quantifier_or_Qualifier Arg1:T12 Arg2:T54	
R9	Causes Arg1:T12 Arg2:T10	
R10	Used_for Arg1:T26 Arg2:T9	
R12	Experiences Arg1:T48 Arg2:T16	
R13	Before Arg1:T6 Arg2:T17	
R14	Experiences Arg1:T48 Arg2:T17	
R15	Experiences Arg1:T49 Arg2:T17	
R16	Experiences Arg1:T49 Arg2:T15	
R17	Experiences Arg1:T49 Arg2:T16	
R18	Used_for Arg1:T33 Arg2:T17	
R19	Combined_with Arg1:T36 Arg2:T18	
R20	Combined_with Arg1:T18 Arg2:T19	
R21	Combined_with Arg1:T33 Arg2:T36	
R22	Combined_with Arg1:T43 Arg2:T38	
R23	Combined_with Arg1:T38 Arg2:T20	
R24	Used_for Arg1:T43 Arg2:T17	
R25	Used_for Arg1:T21 Arg2:T17	
R26	Has_Dose_or_Strength Arg1:T21 Arg2:T44	
R27	Combined_with Arg1:T21 Arg2:T39	
R28	Has_Dose_or_Strength Arg1:T39 Arg2:T45	
R29	Combined_with Arg1:T39 Arg2:T40	
R30	Has_Dose_or_Strength Arg1:T40 Arg2:T47	
R31	Used_for Arg1:T22 Arg2:T17	
R32	Has_Dose_or_Strength Arg1:T24 Arg2:T50	
R33	Has_Frequency Arg1:T24 Arg2:T52	
R34	Has_Duration_or_Interval Arg1:T24 Arg2:T51	
T55	Neg_cue 1217 1219	No
T57	CONC 1248 1259	diferencias
A2	Assertion T57 Negated
#39	AnnotatorNotes T57	C1705241; Delta (difference); Quantitative Concept
R35	Negation Arg1:T55 Arg2:T57	
T58	Neg_cue 1401 1408	ninguno
T59	Result_or_Value 1413 1427	menor de p0,01
A3	Assertion T59 Negated
R36	Negation Arg1:T58 Arg2:T59	
T60	Neg_cue 1459 1461	no
T61	CONC 1477 1485	eficacia
A4	Assertion T61 Negated
#40	AnnotatorNotes T61	C0087113; Treatment Effectiveness; Qualitative Concept
R37	Negation Arg1:T60 Arg2:T61	
R38	Location_of Arg1:T42 Arg2:T31	
T62	Observation 1535 1553	disminución de VSC
A5	Assertion T62 Negated
R40	Negation Arg1:T60 Arg2:T62	
R41	Overlap Arg1:T62 Arg2:T56	
T63	CONC 1353 1373	valores comparativos
R42	Has_Result_or_Value Arg1:T63 Arg2:T59	
R43	Before Arg1:T15 Arg2:T6	
T64	Quantifier_or_Qualifier 1260 1287	estadísticas significativas
A6	Assertion T64 Negated
#41	AnnotatorNotes T64	C0237881; Statistical Significance; Quantitative Concept
R11	Has_Quantifier_or_Qualifier Arg1:T57 Arg2:T64	
R44	Negation Arg1:T55 Arg2:T64	
T65	Observation 1 8	Efectos
#42	AnnotatorNotes T65	C1518681; Outcome of Therapy; Finding (?)
R45	Causes Arg1:T1 Arg2:T65	
R8	Before Arg1:T30 Arg2:T62	
#43	AnnotatorNotes T56	C0443303; short-term; Temporal Concept
A7	Experiencer T49 Patient
A8	Experiencer T48 Patient
